IXC
Click for more information
10.0% 6.3¢ invex therapeutics ltd

Ann: Invex Granted Type C Meeting with FDA, page-7

  1. TheDerivative
    343 Posts.
    lightbulb Created with Sketch. 23
    clock Created with Sketch.
    22/04/21
    12:21
    Post #: 52647817
    Yes and written responses to be provided mid June.
    The Chairman is quoted as being "pleased', so obviously there will be some clarity achieved as a result of the FDA feedback and we can all move on with 1 or 2 trials.
    Share price sitting at these levels is very frustrating though.
    IXC Price at posting: 75.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NOX Noxopharm aims for autoimmune market with first human trial of SOF-SKN
right-arrow Created with Sketch.
NEWS Good habits matters when it comes to finances
right-arrow Created with Sketch.
NEWS Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more
right-arrow Created with Sketch.
WR1 Stock watchers charged up by Winsome Resources' latest lithium drilling results
right-arrow Created with Sketch.
SUM Summit Minerals jumps 6% as LiDAR survey boosts confidence in niobium mineralisation
right-arrow Created with Sketch.
MBK Metal Bank setting up shop in Saudi Arabia as part of MENA expansion plans
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
6.3¢ 		Change
-0.007(10.0%) 		Mkt cap ! $5.260M
Open High Low Value Volume
7.0¢ 7.0¢ 6.3¢ $4.485K 65.57K

Buyers (Bids)

No. Vol. Price($)
1 50000 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 8695 1
View Market Depth
Last trade - 11.20am 20/08/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.